本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Zentalis Pharmaceuticals, LLC

3.08
-0.0550-1.76%
成交量:45.89萬
成交額:144.36萬
市值:2.91億
市盈率:-1.57
高:3.26
開:3.23
低:3.05
收:3.13
52周最高:6.95
52周最低:1.21
股本:9,467.19萬
流通股本:7,528.59萬
量比:0.89
換手率:0.61%
股息:- -
股息率:- -
每股收益(TTM):-1.9591
每股收益(LYR):-1.9100
淨資產收益率:-66.75%
總資產收益率:-33.15%
市淨率:2.03
市盈率(LYR):-1.61

資料載入中...

2021/06/08

重要事件披露

8-K - Current report
2021/05/17

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/17

重要事件披露

8-K - Current report
2021/04/06

重要事件披露

8-K - Current report
2021/03/25

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/25

重要事件披露

8-K - Current report
2021/03/19

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/19

重要事件披露

8-K - Current report
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/10

重要事件披露

8-K - Current report
2021/02/08

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/03

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/02

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/11/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/11/09

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/09

重要事件披露

8-K - Current report